One‐stop‐shop treatment for basal cell carcinoma, part of a new disease management strategy

Background  The number of skin cancer patients, especially patients with basal cell carcinoma (BCC), is rapidly increasing. Resources available at dermato‐oncology units have not increased proportionally, which affects the throughput time of patients.

[1]  F. D. de Gruijl,et al.  Predictions of skin cancer incidence in the Netherlands up to 2015 , 2005, The British journal of dermatology.

[2]  H. F. van Tuijl,et al.  Need for a new skin cancer management strategy. , 2010, Archives of dermatology.

[3]  A. Kopf,et al.  Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. , 1996, Journal of the American Academy of Dermatology.

[4]  S. Salasche,et al.  Interpretation of Mohs micrographic frozen sections: a peer review comparison study. , 1989, Journal of the American Academy of Dermatology.

[5]  F. Overdyk,et al.  One-stop surgery: evolving approach to pediatric outpatient surgery. , 1999, Journal of pediatric surgery.

[6]  M. Jansen-Vullers,et al.  Admission and capacity planning for the implementation of one-stop-shop in skin cancer treatment using simulation-based optimization , 2013, Health care management science.

[7]  Janjaap Semeijn,et al.  International logistics and one‐stop shopping , 1995 .

[8]  C. Lawrence,et al.  A retrospective study of outcome of Mohs’ micrographic surgery for cutaneous squamous cell carcinoma using formalin fixed sections , 2000, The British journal of dermatology.

[9]  P R Yarnold,et al.  Effects of actual waiting time, perceived waiting time, information delivery, and expressive quality on patient satisfaction in the emergency department. , 1996, Annals of emergency medicine.

[10]  H. Reijers,et al.  How to run an effective and efficient dermato‐oncology unit: a Dutch approach , 2009 .